
Regulatory Considerations for Early-Stage Development of Bi-, Tri-, and Multi-Specific Therapeutics
Speaker Presentation: CMC Strategy Forum North America 2026
Parmar Hiren, Health Canada, 2026
Regulatory Considerations for Early-Stage Development of Bi-, Tri-, and Multi-Specific Therapeutics